Moderate Pain Archives

Baudax Bio Wins FDA Approval for Non-Opioid Pain Treatment Anjeso

Approvals, Business, FDA, FDA/Regulatory, Moderate Pain, New Drug Application (NDA), Severe Pain, Shares

Shares of Pennsylvania-based Baudax Bio were up more than 40 percent after the company announced that the pain medication Anjeso was greenlit by the U.S. Food and Drug Administration.

February 21, 2020/by BioSpace

FDA Action Alert: Merck, Baudax Bio, Alder and Esperion

Blockbusters, FDA, FDA/Regulatory, Moderate Pain, Oncology, Pain, Severe Pain, Supplemental Biologics License Application (sBLA)

The U.S. Food and Drug Administration’s busy schedule for drug reviews includes six supplemental BLAs for Merck’s blockbuster oncology brand Keytruda.

February 17, 2020/by BioSpace